- Home
- NEO vs MCRI Comparison
NEO vs MCRI Comparison
Compare NEO & MCRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEO | MCRI |
|---|---|---|
| Founded | 2001 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2008 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NEO | MCRI |
|---|---|---|
| Price | $9.91 | $96.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | $11.50 | ★ $100.50 |
| AVG Volume (30 Days) | ★ 1.7M | 98.8K |
| Earning Date | 05-18-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.18 |
| Revenue | N/A | ★ $395,377,000.00 |
| Revenue This Year | $10.53 | $4.85 |
| Revenue Next Year | $9.25 | $2.21 |
| P/E Ratio | ★ N/A | $22.82 |
| Revenue Growth | N/A | ★ 114.40 |
| 52 Week Low | $4.72 | $69.99 |
| 52 Week High | $13.74 | $113.88 |
Technical Indicators
Market Signals| Indicator | NEO | MCRI |
|---|---|---|
| Relative Strength Index (RSI) | 29.37 | 55.66 |
| Support Level | $9.28 | $92.25 |
| Resistance Level | $11.65 | $96.41 |
| Average True Range (ATR) | 0.66 | 3.15 |
| MACD | -0.20 | 0.18 |
| Stochastic Oscillator | 23.86 | 61.44 |
Price Performance
Historical ComparisonAbout NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.